Company · CIK 0001416792 · SIC 2834 — Pharmaceutical Preparations
Relypsa Inc · RLYP
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2015 AForm 4 → | Jun 8, 8:50 pm EDT | Helen TorleyDirector | 2,250 | — | — | 2,250 | — | plan? |
| May 29, 2015 SForm 4 → | Jun 2, 8:24 pm EDT | John A OrwinPresident & CEO, Director | 33,555 | $36.42 | $1,222,149 | 30,000 | −52.8% | plan? |
| May 29, 2015 MForm 4 → | Jun 2, 8:24 pm EDT | John A OrwinPresident & CEO, Director | 28,555 | $7.40 | $211,307 | 43,555 | — | plan? |
| May 18, 2015 SForm 4 → | May 20, 8:30 pm EDT | ORBIMED ADVISORS LLC +210% Owner | 1,457,551 | $34.13 | $49,746,216 | 7,400,000 | −16.5% | plan? |
| May 11, 2015 SForm 4 → | May 13, 7:00 pm EDT | Klaus R Dr VeitingerDirector | 5,834 | $36.06 | $210,387 | 2,712 | −68.3% | plan? |
| May 11, 2015 MForm 4 → | May 13, 7:00 pm EDT | Klaus R Dr VeitingerDirector | 5,834 | $3.96 | $23,103 | 8,546 | — | plan? |
| Apr 10, 2015 SForm 4 → | Apr 13, 6:09 pm EDT | Klaus R Dr VeitingerDirector | 5,832 | $35.35 | $206,179 | 2,712 | −68.3% | plan? |
| Apr 10, 2015 MForm 4 → | Apr 13, 6:09 pm EDT | Klaus R Dr VeitingerDirector | 5,832 | $3.96 | $23,095 | 8,544 | — | plan? |
| Mar 10, 2015 SForm 4 → | Mar 12, 6:21 pm EDT | Klaus R Dr VeitingerDirector | 5,834 | $38.67 | $225,594 | 2,712 | −68.3% | plan? |
| Mar 10, 2015 MForm 4 → | Mar 12, 6:21 pm EDT | Klaus R Dr VeitingerDirector | 5,834 | $4.35 | $25,401 | 8,546 | — | plan? |
| Mar 5, 2015 MForm 4 → | Mar 5, 8:24 pm EST | Kristine M BallChief Financial Officer & SVP | 3,000 | $3.96 | $11,880 | 10,500 | — | plan? |
| Mar 4, 2015 SForm 4 → | Mar 6, 7:19 pm EST | Claire LockeySee Remarks | 10,000 | $40.00 | $400,000 | 5,500 | −64.5% | plan? |
| Mar 4, 2015 MForm 4 → | Mar 6, 7:19 pm EST | Claire LockeySee Remarks | 10,000 | $4.57 | $45,685 | 15,500 | — | plan? |
| Mar 3, 2015 SForm 4 → | Mar 5, 8:24 pm EST | Kristine M BallChief Financial Officer & SVP | 3,519 | $40.68 | $143,137 | 7,500 | −31.9% | plan? |
| Feb 25, 2015 SForm 4 → | Feb 27, 8:55 pm EST | Ronald A. KrasnowSee Remarks | 10,348 | $39.00 | $403,572 | 5,500 | −65.3% | plan? |
| Feb 24, 2015 SForm 4 → | Feb 25, 6:33 pm EST | Lance BermanChief Medical Officer and SVP | 5,000 | $38.19 | $190,949 | 7,500 | −40.0% | plan? |
| Feb 24, 2015 MForm 4 → | Feb 25, 6:33 pm EST | Lance BermanChief Medical Officer and SVP | 5,000 | $5.23 | $26,130 | 12,500 | — | plan? |
| Feb 23, 2015 SForm 4 → | Feb 25, 11:44 am EST | Ronald A. KrasnowSee Remarks | 10,000 | $39.00 | $390,000 | 15,848 | −38.7% | plan? |
| Feb 10, 2015 SForm 4 → | Feb 10, 9:06 pm EST | Klaus R Dr VeitingerDirector | 5,834 | $32.12 | $187,359 | 2,712 | −68.3% | plan? |
| Feb 10, 2015 MForm 4 → | Feb 10, 9:06 pm EST | Klaus R Dr VeitingerDirector | 5,834 | $4.65 | $27,128 | 8,546 | — | plan? |
| Jan 21, 2015 SForm 4 → | Jan 23, 9:45 pm EST | Ronald A. KrasnowSee Remarks | 55,000 | $35.00 | $1,925,000 | 25,848 | −68.0% | plan? |
| Jan 21, 2015 MForm 4 → | Jan 23, 9:45 pm EST | Ronald A. KrasnowSee Remarks | 55,000 | $3.78 | $208,103 | 80,848 | — | plan? |
| Jan 21, 2015 SForm 4 → | Jan 23, 9:44 pm EST | Kristine M BallChief Financial Officer & SVP | 3,000 | $36.00 | $108,000 | 7,500 | −28.6% | plan? |
| Jan 21, 2015 MForm 4 → | Jan 23, 9:44 pm EST | Kristine M BallChief Financial Officer & SVP | 3,000 | $3.96 | $11,880 | 10,500 | — | plan? |
| Jan 21, 2015 SForm 4 → | Jan 23, 9:43 pm EST | Claire LockeySee Remarks | 5,000 | $35.00 | $175,000 | 5,500 | −47.6% | plan? |
| Jan 21, 2015 MForm 4 → | Jan 23, 9:43 pm EST | Claire LockeySee Remarks | 5,000 | $4.65 | $23,250 | 10,500 | — | plan? |
| Jan 14, 2015 SForm 4 → | Jan 16, 7:43 pm EST | Ronald A. KrasnowSee Remarks | 5,000 | $33.58 | $167,895 | 25,848 | −16.2% | plan? |
| Jan 14, 2015 MForm 4 → | Jan 16, 7:43 pm EST | Ronald A. KrasnowSee Remarks | 5,000 | $2.76 | $13,800 | 30,848 | — | plan? |
| Jan 12, 2015 SForm 4 → | Jan 14, 11:15 am EST | Klaus R Dr VeitingerDirector | 5,834 | $32.33 | $188,589 | 2,712 | −68.3% | plan? |
| Jan 12, 2015 MForm 4 → | Jan 14, 11:15 am EST | Klaus R Dr VeitingerDirector | 5,834 | $4.65 | $27,128 | 8,546 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2016 DForm 4 → | Sep 2, 12:39 pm EDT | Helen TorleyDirector | 21,000 | — | — | 0 | — | |
| Sep 1, 2016 DForm 4 → | Sep 2, 12:38 pm EDT | Daniel K SpiegelmanDirector | 21,000 | — | — | 0 | — | |
| Sep 1, 2016 DForm 4 → | Sep 2, 12:37 pm EDT | Thomas J. SchuetzDirector | 57,849 | — | — | 0 | — | |
| Sep 1, 2016 DForm 4 → | Sep 2, 12:37 pm EDT | David W J McGirrDirector | 78,200 | — | — | 0 | — | |
| Sep 1, 2016 DForm 4 → | Sep 2, 12:35 pm EDT | Kenneth J. HillanDirector | 21,000 | — | — | 0 | — | |
| Sep 1, 2016 DForm 4 → | Sep 2, 12:34 pm EDT | Paul J HastingsDirector | 50,583 | — | — | 0 | — | |
| Sep 1, 2016 DForm 4 → | Sep 2, 12:33 pm EDT | John P. ButlerDirector | 37,460 | — | — | 0 | — | |
| Sep 1, 2016 ADForm 4 → | Sep 2, 12:32 pm EDT | Wilhelm StahlSVP, Chief Technology Officer | 190,312 | — | — | 0 | — | |
| Sep 1, 2016 ADForm 4 → | Sep 2, 12:31 pm EDT | John A OrwinPresident & CEO, Director | 1,039,877 | — | — | 0 | — | |
| Sep 1, 2016 DForm 4 → | Sep 2, 12:30 pm EDT | Monte MontgomeryChief Accounting Officer | 30,166 | — | — | 0 | — | |
| Sep 1, 2016 ADForm 4 → | Sep 2, 12:29 pm EDT | Ronald A. KrasnowSee Remarks | 185,605 | — | — | 0 | — | |
| Sep 1, 2016 ADForm 4 → | Sep 2, 12:28 pm EDT | Stephen D HarrisonSVP & Chief Scientific Officer | 151,667 | — | — | 0 | — | |
| Sep 1, 2016 ADForm 4 → | Sep 2, 12:27 pm EDT | J. Scott GarlandSVP & Chief Commercial Officer | 176,667 | — | — | 0 | — | |
| Sep 1, 2016 ADForm 4 → | Sep 2, 12:26 pm EDT | Mary CorbettSenior VP, Human Resources | 128,167 | — | — | 0 | — | |
| Sep 1, 2016 ADForm 4 → | Sep 2, 12:26 pm EDT | Lance BermanChief Medical Officer and SVP | 173,014 | — | — | 0 | — | |
| Sep 1, 2016 ADForm 4 → | Sep 2, 12:25 pm EDT | Kristine M BallChief Financial Officer & SVP | 281,642 | — | — | 0 | — | |
| Aug 11, 2016 PForm 4 → | Aug 15, 6:21 pm EDT | James D Dondero10% Owner | 5,000 | $0.15 | $750 | 65,799 | — | |
| Aug 5, 2016 PForm 4 → | Aug 9, 7:05 pm EDT | James D Dondero10% Owner | 3,300 | $0.15 | $495 | 60,799 | — | |
| Jun 21, 2016 AForm 4 → | Jun 23, 5:57 pm EDT | Helen TorleyDirector | 4,500 | — | — | 4,500 | — | |
| Jun 21, 2016 AForm 4 → | Jun 23, 5:56 pm EDT | David W J McGirrDirector | 4,500 | — | — | 4,500 | — | |
| Jun 21, 2016 AForm 4 → | Jun 23, 5:55 pm EDT | Kenneth J. HillanDirector | 4,500 | — | — | 4,500 | — | |
| Jun 21, 2016 AForm 4 → | Jun 23, 5:55 pm EDT | Paul J HastingsDirector | 4,500 | — | — | 4,500 | — | |
| Jun 21, 2016 AForm 4 → | Jun 23, 5:53 pm EDT | John P. ButlerDirector | 4,500 | — | — | 4,500 | — | |
| Jun 21, 2016 AForm 4 → | Jun 23, 5:52 pm EDT | Daniel K SpiegelmanDirector | 4,500 | — | — | 4,500 | — | |
| Jun 21, 2016 AForm 4 → | Jun 23, 5:52 pm EDT | Thomas J. SchuetzDirector | 4,500 | — | — | 4,500 | — | |
| Jun 3, 2016 AForm 4 → | Jun 7, 6:53 pm EDT | Ronald A. KrasnowSee Remarks | 5,833 | — | — | 5,833 | — | |
| Jun 3, 2016 AForm 4 → | Jun 7, 6:51 pm EDT | Wilhelm StahlSVP, Chief Technology Officer | 5,833 | — | — | 5,833 | — | |
| Jun 3, 2016 AForm 4 → | Jun 7, 6:50 pm EDT | J. Scott GarlandSVP & Chief Commercial Officer | 8,333 | — | — | 8,333 | — | |
| Jun 3, 2016 AForm 4 → | Jun 7, 6:49 pm EDT | Stephen D HarrisonSVP & Chief Scientific Officer | 8,333 | — | — | 8,333 | — | |
| Jun 3, 2016 AForm 4 → | Jun 7, 6:48 pm EDT | Lance BermanChief Medical Officer and SVP | 8,333 | — | — | 8,333 | — | |
| Jun 3, 2016 AForm 4 → | Jun 7, 6:48 pm EDT | Mary CorbettSenior VP, Human Resources | 5,833 | — | — | 5,833 | — | |
| Jun 3, 2016 AForm 4 → | Jun 7, 6:47 pm EDT | John A OrwinPresident & CEO, Director | 22,500 | — | — | 22,500 | — | |
| Jun 3, 2016 AForm 4 → | Jun 7, 6:46 pm EDT | Kristine M BallChief Financial Officer & SVP | 8,333 | — | — | 8,333 | — | |
| Dec 31, 2015 MForm 4 → | Jan 4, 2016, 5:27 pm EST | Wilhelm StahlSVP, Chief Technology Officer | 20,000 | — | — | 46,597 | — | |
| Dec 7, 2015 MForm 4 → | Dec 9, 8:24 pm EST | John A OrwinPresident & CEO, Director | 10,000 | — | — | 727,877 | — | |
| Dec 7, 2015 MForm 4 → | Dec 9, 8:23 pm EST | Lance BermanChief Medical Officer and SVP | 30,750 | — | — | 25,414 | — | |
| Dec 2, 2015 MForm 4 → | Dec 4, 5:50 pm EST | John A OrwinPresident & CEO, Director | 40,000 | — | — | 737,877 | — | |
| Aug 10, 2015 AForm 4 → | Aug 12, 9:27 pm EDT | John A OrwinPresident & CEO, Director | 105,000 | — | — | 105,000 | — | |
| Aug 10, 2015 AForm 4 → | Aug 12, 9:27 pm EDT | Claire LockeySee Remarks | 24,500 | — | — | 24,500 | — | |
| Aug 10, 2015 AForm 4 → | Aug 12, 9:26 pm EDT | Ronald A. KrasnowSee Remarks | 24,500 | — | — | 24,500 | — | |
| Aug 10, 2015 AForm 4 → | Aug 12, 9:25 pm EDT | Stephen D HarrisonSVP & Chief Scientific Officer | 35,000 | — | — | 35,000 | — | |
| Aug 10, 2015 AForm 4 → | Aug 12, 9:24 pm EDT | J. Scott GarlandSVP & Chief Commercial Officer | 35,000 | — | — | 35,000 | — | |
| Aug 10, 2015 AForm 4 → | Aug 12, 9:23 pm EDT | Mary CorbettSVP, Human Resources | 24,500 | — | — | 24,500 | — | |
| Aug 10, 2015 AForm 4 → | Aug 12, 9:22 pm EDT | Lance BermanChief Medical Officer and SVP | 38,500 | — | — | 38,500 | — | |
| Aug 10, 2015 AForm 4 → | Aug 12, 9:22 pm EDT | Kristine M BallChief Financial Officer & SVP | 38,500 | — | — | 38,500 | — | |
| Aug 10, 2015 AForm 4 → | Aug 12, 9:21 pm EDT | Wilhelm StahlSVP, Chief Technology Officer | 24,500 | — | — | 24,500 | — | |
| Jul 30, 2015 MForm 4 → | Aug 3, 8:43 pm EDT | John A OrwinPresident & CEO, Director | 25,000 | — | — | 777,877 | — | |
| Jun 4, 2015 AForm 4 → | Jun 9, 11:55 am EDT | David W J McGirrDirector | 4,500 | — | — | 4,500 | — | late |
| Jun 4, 2015 AForm 4 → | Jun 8, 8:55 pm EDT | Daniel K SpiegelmanDirector | 4,500 | — | — | 4,500 | — | |
| Jun 4, 2015 AForm 4 → | Jun 8, 8:53 pm EDT | Kenneth J. HillanDirector | 4,500 | — | — | 4,500 | — | |
| Jun 4, 2015 AForm 4 → | Jun 8, 8:52 pm EDT | Paul J HastingsDirector | 4,500 | — | — | 4,500 | — | |
| Jun 4, 2015 AForm 4 → | Jun 8, 8:52 pm EDT | John P. ButlerDirector | 4,500 | — | — | 4,500 | — | |
| Jun 4, 2015 AForm 4 → | Jun 8, 8:51 pm EDT | Thomas J. SchuetzDirector | 4,500 | — | — | 4,500 | — | |
| Jun 4, 2015 AForm 4 → | Jun 8, 8:50 pm EDT | Helen TorleyDirector | 4,500 | — | — | 4,500 | — | |
| May 29, 2015 MForm 4 → | Jun 2, 8:24 pm EDT | John A OrwinPresident & CEO, Director | 28,555 | — | — | 802,877 | — | |
| May 11, 2015 MForm 4 → | May 13, 7:00 pm EDT | Klaus R Dr VeitingerDirector | 5,834 | — | — | 69,543 | — | |
| Apr 10, 2015 MForm 4 → | Apr 13, 6:09 pm EDT | Klaus R Dr VeitingerDirector | 5,832 | — | — | 75,377 | — | |
| Mar 10, 2015 MForm 4 → | Mar 12, 6:21 pm EDT | Klaus R Dr VeitingerDirector | 5,834 | — | — | 81,209 | — | |
| Mar 5, 2015 MForm 4 → | Mar 5, 8:24 pm EST | Kristine M BallChief Financial Officer & SVP | 3,000 | — | — | 122,872 | — | |
| Mar 4, 2015 MForm 4 → | Mar 6, 7:19 pm EST | Claire LockeySee Remarks | 10,000 | — | — | 25,214 | — | |
| Feb 24, 2015 MForm 4 → | Feb 25, 6:33 pm EST | Lance BermanChief Medical Officer and SVP | 5,000 | — | — | 30,919 | — | |
| Feb 10, 2015 MForm 4 → | Feb 10, 9:06 pm EST | Klaus R Dr VeitingerDirector | 5,834 | — | — | 16,126 | — | |
| Jan 22, 2015 AForm 4 → | Jan 26, 7:14 pm EST | Helen TorleyDirector | 12,000 | — | — | 12,000 | — | |
| Jan 21, 2015 MForm 4 → | Jan 23, 9:45 pm EST | Ronald A. KrasnowSee Remarks | 55,000 | — | — | 37,611 | — | |
| Jan 21, 2015 MForm 4 → | Jan 23, 9:44 pm EST | Kristine M BallChief Financial Officer & SVP | 3,000 | — | — | 125,872 | — | |
| Jan 21, 2015 MForm 4 → | Jan 23, 9:43 pm EST | Claire LockeySee Remarks | 5,000 | — | — | 9,267 | — | |
| Jan 14, 2015 MForm 4 → | Jan 16, 7:43 pm EST | Ronald A. KrasnowSee Remarks | 5,000 | — | — | 8,081 | — | |
| Jan 12, 2015 MForm 4 → | Jan 14, 11:15 am EST | Klaus R Dr VeitingerDirector | 5,834 | — | — | 21,960 | — | |
| Jan 2, 2015 AForm 4 → | Jan 6, 5:00 pm EST | Stephen D HarrisonSVP & Chief Scientific Officer | 75,000 | — | — | 75,000 | — |